STRS Ohio’s Greenwich LifeSciences GLSI Stock Holding History

STRS Ohio’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$418K	Buy	17,800 +4,100	+30%	+$99.8K	﹤0.01%	1239
2026 Q1	$329K	Buy	13,700 +8,000	+140%	+$209K	﹤0.01%	1280
2025 Q4	$120K	Sell	5,700 -14,300	-72%	-$151K	﹤0.01%	1756
2025 Q3	$199K	Hold	20,000	–	–	﹤0.01%	1545
2025 Q2	$181K	Buy	20,000 +1,400	+8%	+$13.3K	﹤0.01%	1695
2025 Q1	$177K	Hold	18,600	–	–	﹤0.01%	1543
2024 Q4	$209K	Buy	18,600 +5,800	+45%	+$77.6K	﹤0.01%	1492
2024 Q3	$184K	Buy	12,800 +8,000	+167%	+$119K	﹤0.01%	1578
2024 Q2	$82.8K	Buy	+4,800	New	+$70.1K	﹤0.01%	1730
2022 Q2	–	Sell	-900	Closed	-$17K	–	2134
2022 Q1	$17K	Hold	900	–	–	﹤0.01%	2059
2021 Q4	$21K	Hold	900	–	–	﹤0.01%	2108
2021 Q3	$35K	Hold	900	–	–	﹤0.01%	2119
2021 Q2	$40K	Buy	+900	New	+$34K	﹤0.01%	2132

Other funds holding GLSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

STRS Ohio's GLSI Position: Q2 2026 in Review

STRS Ohio increased its Greenwich LifeSciences (GLSI) stake by 30% in Q2 2026, buying an estimated $99.8K and bringing the position to 17,800 shares worth $418K. The position accounts for ﹤0.01% of the portfolio, ranked #1239.

STRS Ohio first reported a position in GLSI in Q2 2021 and has held it in 13 quarters since. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

STRS Ohio held 17,800 shares of Greenwich LifeSciences worth $418K as of Q2 2026.
STRS Ohio bought 4,100 Greenwich LifeSciences shares in Q2 2026, an estimated $99.8K.
Greenwich LifeSciences made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1239 holding.
STRS Ohio first reported a position in Greenwich LifeSciences in Q2 2021 and has held it in 13 quarters since.
58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.